Home

Using an Ultrasonic Instrument to Size Extravascular Bubbles

Measurements could be used to guide prebreathing of oxygen to reduce the risk of decompression sickness.

In an ongoing development project, microscopic bubbles in extravascular tissue in a human body will be detected by use of an enhanced version of the apparatus described in "Ultrasonic Bubble- Sizing Instrument" (MSC-22980), NASA Tech Briefs, Vol.24, No.10 (October 2000), page 62. To recapitulate: The physical basis of the instrument is the use of ultrasound to excite and measure the resonant behavior (oscillatory ex- pansion and contraction) of bubbles. The resonant behavior is a function of the bubble diameter; the instrument exploits the diameter dependence of the resonance frequency and the general nonlinearity of the ultrasonic response of bubbles to detect bubbles and potentially measure their diameters.

In the cited prior article, the application given most prominent mention was the measurement of gaseous emboli (essentially, gas bubbles in blood vessels) that cause decompression sickness and complications associated with cardiopulmonary surgery. According to the present proposal, the instrument capabilities would be extended to measure extravascular bubbles with diameters in the approximate range of 1 to 30 µm.

The proposed use of the instrument could contribute further to the understanding and prevention of decompression sickness: There is evidence that suggests that prebreathing oxygen greatly reduces the risk of decompression sickness by reducing the number of microscopic extravascular bubbles. By using the ultrasonic bubble-sizing instrument to detect and/or measure the sizes of such bubbles, it might be possible to predict the risk of decompression sickness. The instrument also has potential as a tool to guide the oxygen-prebreathing schedules of astronauts; high-altitude aviators; individuals who undertake high-altitude, low-opening (HALO) parachute jumps; and others at risk of decompression sickness. For example, an individual at serious risk of decompression sickness because of high concentrations of extravascular microscopic bubbles could be given a warning to continue to prebreathe oxygen until it was safe to decompress.

This work was done by Patrick J. Magari, Robert J. Kline-Schoder, and Marc A. Kenton of Creare, Inc., for Johnson Space Center. For further information, contact: Creare, Inc. P.O. Box 71 Hanover, NH 03755 Phone: (603)643-3800 Fax: (603)643-4657 E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.%20" >This email address is being protected from spambots. You need JavaScript enabled to view it.

Refer to MSC-23128.